Multivariable adjusted ORs and 95% confidence intervals of colorectal and colon cancer by median levels of IGF-1, C-peptide, IGF-1/IGFBP3 ratio and vitamin D, HPFS and NHS combined. This evidence concerns the gene IGFBP3 and colonic neoplasm.